Interleukin-17 deficiency improves locomotor recovery and tissue sparing after spinal cord contusion injury in mice

Publisher:
Elsevier Ireland Ltd
Publication Type:
Journal Article
Citation:
Neuroscience Letters, 2011, 487 (3), pp. 363 - 367
Issue Date:
2011-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010001188OK.pdf404.92 kB
Adobe PDF
Following the initial impact, spinal cord injury (SCI) triggers a number of inflammatory responses which can exacerbate tissue damage in the cord and impair functional recovery. The involvement of several pro-inflammatory cytokines in the secondary degenerative mechanisms of SCI has been well established, although the role of interleukin-17 (IL-17) remains unclear. In the present study, we used IL-17 knockout (KO) and C57BL/6J wildtype (WT) mice to investigate the effects of IL-17 deficiency on locomotor recovery, lesion size, glial activation and inflammatory cell response following spinal cord contusion injury. Our results show that compared to WT mice, IL-17 KO mice had a significantly smaller lesion size, corresponding with significantly improved locomotor functional recovery following SCI. At 6 weeks after injury, recruitment of B cells, dendritic cells and neutrophils was significantly lower in IL-17 KO than WT mice, however there was no difference in the presence of activated microglia and reactive astrocytes, in the injured spinal cord. These findings suggest that IL-17 is a mediator of secondary degeneration, which contributes to neuroinflammation and hinders functional recovery, though its actions do not affect glial activation following SCI.
Please use this identifier to cite or link to this item: